2017
DOI: 10.1016/j.jtho.2017.06.037
|View full text |Cite
|
Sign up to set email alerts
|

Proteogenomic Landscape of Squamous Cell Lung Cancer

Abstract: Background: It is becoming increasingly appreciated that proper pretreatment diagnostics are essential for determining the appropriate

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
2
0

Year Published

2023
2023
2023
2023

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(2 citation statements)
references
References 0 publications
0
2
0
Order By: Relevance
“…To further compare the different protein inference methods, they were finally tested on two sets of less engineered data, sets without known relative abundance differences. Data were downloaded from Stewart et al, a set consisting of DIA data contrasting lung squamous cell carcinomas to adjacent tissues, 14 and from Gao et al, a set comparing primary to metastatic cell lines. 15 Peptide abundances were derived with the nf-core quantms pipeline followed by our protein summarization strategies and plotted the number of differentially abundant proteins as a function of each method's estimated quantitative protein-level FDR or q value.…”
Section: Benchmark On Cancer Proteomics-related Datamentioning
confidence: 99%
See 1 more Smart Citation
“…To further compare the different protein inference methods, they were finally tested on two sets of less engineered data, sets without known relative abundance differences. Data were downloaded from Stewart et al, a set consisting of DIA data contrasting lung squamous cell carcinomas to adjacent tissues, 14 and from Gao et al, a set comparing primary to metastatic cell lines. 15 Peptide abundances were derived with the nf-core quantms pipeline followed by our protein summarization strategies and plotted the number of differentially abundant proteins as a function of each method's estimated quantitative protein-level FDR or q value.…”
Section: Benchmark On Cancer Proteomics-related Datamentioning
confidence: 99%
“…The first set consists of data from four frozen lung squamous cell carcinomas and four adjacent tissues harvested with a Thermo QExactive Plus. 14 The second set consists of data from a comparison of three primary cell lines (SK-MEL-1, A375, and G-361) to three metastatic (RPMI-7951, SH-4, and SK-MEL-3) cell lines analyzed (two samples per cell line) by a Thermo Orbitrap Fusion Lumos Tribrid. 15…”
Section: Cancer Proteomics Datamentioning
confidence: 99%